Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest RTW INVESTMENTS, LP Stock Portfolio

$6.46Billion– No. of Holdings #68

RTW INVESTMENTS, LP Performance:
2024 Q2: -0.62%YTD: 7.04%2023: 4.11%

Performance for 2024 Q2 is -0.62%, and YTD is 7.04%, and 2023 is 4.11%.

About RTW INVESTMENTS, LP and 13F Hedge Fund Stock Holdings

RTW INVESTMENTS, LP is a hedge fund based in NEW YORK, NY. On 30-May-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $7.2 Billions. In it's latest 13F Holdings report, RTW INVESTMENTS, LP reported an equity portfolio of $6.5 Billions as of 30 Jun, 2024.

The top stock holdings of RTW INVESTMENTS, LP are MDGL, RCKT, AXSM. The fund has invested 8.3% of it's portfolio in MADRIGAL PHARMACEUTICALS INC and 5.9% of portfolio in ROCKET PHARMACEUTICALS INC.

The fund managers got completely rid off AVADEL PHARMACEUTICALS PLC (AVDL), STRYKER CORPORATION (SYK) and SHOCKWAVE MED INC (SWAV) stocks. They significantly reduced their stock positions in ADICET BIO INC (ACET), 10X GENOMICS INC (TXG) and ULTRAGENYX PHARMACEUTICAL IN (RARE). RTW INVESTMENTS, LP opened new stock positions in CULLINAN THERAPEUTICS INC (CGEM), TEMPUS AI INC and REPLIMUNE GROUP INC (REPL). The fund showed a lot of confidence in some stocks as they added substantially to GLAUKOS CORP (GKOS), MADRIGAL PHARMACEUTICALS INC (MDGL) and CG ONCOLOGY INC.
RTW INVESTMENTS, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024

RTW INVESTMENTS, LP Annual Return Estimates Vs S&P 500

Our best estimate is that RTW INVESTMENTS, LP made a return of -0.62% in the last quarter. In trailing 12 months, it's portfolio return was 9.98%.

New Buys

Ticker$ Bought
cullinan therapeutics inc18,357,900
tempus ai inc14,000,000
replimune group inc10,204,100
perceptive cap solutions cor7,469,550
arca biopharma inc5,362,000
structure therapeutics inc4,908,750
cytomx therapeutics inc1,464,000

New stocks bought by RTW INVESTMENTS, LP

Additions


Additions to existing portfolio by RTW INVESTMENTS, LP

Reductions

Ticker% Reduced
adicet bio inc-74.52
10x genomics inc-67.66
ultragenyx pharmaceutical in-54.00
vericel corp-50.11
sagimet biosciences inc-49.96
immunocore hldgs plc-19.1
sab biotherapeutics inc-16.44
arvinas inc-10.01

RTW INVESTMENTS, LP reduced stake in above stock

RTW INVESTMENTS, LP got rid off the above stocks

Sector Distribution

RTW INVESTMENTS, LP has about 87.1% of it's holdings in Healthcare sector.

Sector%
Healthcare87.1
Others12.9

Market Cap. Distribution

RTW INVESTMENTS, LP has about 9.5% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP55.4
SMALL-CAP19.1
UNALLOCATED15.4
LARGE-CAP9.5

Stocks belong to which Index?

About 60.8% of the stocks held by RTW INVESTMENTS, LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200059.4
Others39.2
S&P 5001.4
Top 5 Winners (%)%
INSM
insmed inc
149.3 %
RNA
avidity biosciences inc
59.5 %
REPL
replimune group inc
34.3 %
MRUS
merus n v
31.3 %
DYN
dyne therapeutics inc
27.4 %
Top 5 Winners ($)$
INSM
insmed inc
146.1 M
RNA
avidity biosciences inc
134.2 M
MDGL
madrigal pharmaceuticals inc
76.8 M
MRUS
merus n v
58.9 M
DYN
dyne therapeutics inc
48.5 M
Top 5 Losers (%)%
RCKT
rocket pharmaceuticals inc
-79.7 %
RGNX
regenxbio inc
-44.5 %
SAGE
sage therapeutics inc
-42.0 %
ACET
adicet bio inc
-40.1 %
TXG
10x genomics inc
-37.3 %
Top 5 Losers ($)$
BRKR
bruker corp
-101.9 M
RCKT
rocket pharmaceuticals inc
-95.7 M
ARVN
arvinas inc
-46.4 M
SAGE
sage therapeutics inc
-43.2 M
CYTK
cytokinetics inc
-41.4 M

RTW INVESTMENTS, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of RTW INVESTMENTS, LP

RTW INVESTMENTS, LP has 68 stocks in it's portfolio. About 48.8% of the portfolio is in top 10 stocks. BRKR proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for RTW INVESTMENTS, LP last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions